SEC Form 4 · accession 0001437749-15-009013
HYPERION THERAPEUTICS INC · HPTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Frederick Scharschmidt
Officer — SVP & Chief Medical Officer
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 1, 2015 | M | 2,186 | $4.08 | A | 99,669 | D | |
| Common Stock | May 1, 2015 | M | 4,789 | $7.31 | A | 104,458 | D | |
| Common Stock | holding | — | — | — | 24,436 | I | By The Bruce Frederick Scharschmidt and Peggy Sue Crawford Family Trust dated October 9, 2001 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $4.08 | May 1, 2015 | M | 2,186 | D | — | Apr 14, 2021 | Common Stock | 2,186 | 0 | D |
| Employee Stock Option (right to buy)F1 | $7.31 | May 1, 2015 | M | 4,789 | D | — | Apr 15, 2022 | Common Stock | 4,789 | 25,227 | D |
Explanation of responses
- F1The option was vested and exercisable on the date of exercise.